Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma

详细信息    查看全文

• 作者：Koviljka Matuš ; an-Ilijaš ; ^a ; ^{kmatusan@medri.hr} ; Giuseppe Damante^b ; Dora Fabbro^c ; Gordana Đ ; orđ ; ević ; ^a ; Ita Hadž ; isejdić ; ^a ; Maja Grahovac^d ; Ivana Marić ; ^e ; Josip Š ; panjol^f ; Blaž ; enka Grahovac^a ; Nives Jonjić ; ^a ; Ksenija Luč ; in^a
• 关键词：Apoptosis ; Carcinoma ; Renal cell ; Nuclear factor kappa B ; Osteopontin
• 刊名：Pathology - Research and Practice
• 出版年：2011
• 出版时间：15 February 2011
• 年：2011
• 卷：207
• 期：2
• 页码：104-110
• 全文大小：1140 K

文摘

Osteopontin (OPN) is a phosphoglycoprotein implicated in tumorigenesis and tumor cell metastasis. Apoptosis inhibition is one of the mechanisms that contribute to development and progression of cancer, and might be initiated by OPN interaction with tumor cells. The aim of this study was to analyze the relation between OPN and nuclear factor-kappa B (NF-κB) expression in clear cell renal cell carcinoma (CCRCC), as well as their relation to apoptotic activity of tumor cells.

Expression of OPN protein and p65 NF-κB subunit was analyzed immunohistochemically in 87 CCRCC samples, and compared mutually and with apoptotic index. Expression of OPN mRNA was analyzed using quantitative real-time PCR and compared with OPN and NF-κB protein expression in 22 CCRCC samples.

Statistical analysis showed an association of p65 NF-κB with OPN mRNA (p = 0.015) and protein (p < 0.001). Also, we found an inverse relationship of OPN with NF-κB protein expression and apoptotic activity of tumor cells (p = 0.006 and p = 0.022, respectively). Our results indicate that p65 NF-κB signaling pathway may be involved in OPN-mediated CCRCC progression, partly by protecting tumor cells from apoptosis. Therefore, both molecules can constitute potential targets for therapeutic intervention in CCRCC.